4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-042545
Chief Financial Officer sold 230,645 shares at $0.55 ($126,901)
- Chief Financial Officer acquired 230,645 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mostafa Adam S. Chief Financial Officer | 2024-10-04 | Grant or award | +230,645 | 230,645 | D | ||
| Mostafa Adam S. Chief Financial Officer | 2024-10-07 | Sale | −230,645 | $0.55 | $126,901 | 0 | D |
| Open-market sales · 230,645 sh · avg $0.55 · $126,901 | |||||||
Loading xslF345X05/wk-form4_1728420276.xml…